At the time of writing, Novartis AG ADR [NVS] stock is trading at $119.38, up 0.74%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NVS shares have lost -0.38% over the last week, with a monthly amount glided 8.68%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on September 03, 2024, when Jefferies downgraded its rating to a Hold. Previously, Deutsche Bank downgraded its rating to Hold on July 19, 2024. On May 30, 2024, Goldman initiated with a Buy rating and assigned a price target of $120 on the stock. BMO Capital Markets started tracking the stock assigning a Market Perform rating and suggested a price target of $114 on February 23, 2024. Morgan Stanley initiated its recommendation with a Equal-Weight and recommended $114 as its price target on January 23, 2024. In a note dated December 18, 2023, HSBC Securities downgraded an Hold rating on this stock.
For the past year, the stock price of Novartis AG ADR fluctuated between $91.70 and $120.92. Currently, Wall Street analysts expect the stock to reach $113 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $119.38 at the most recent close of the market. An investor can expect a potential drop of -5.34% based on the average NVS price forecast.
Analyzing the NVS fundamentals
According to Novartis AG ADR [NYSE:NVS], the company’s sales were 47.55B for trailing twelve months, which represents an -8.15% plunge. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.34%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.39 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.66.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 118.64 points at the first support level, and at 117.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 119.77, and for the 2nd resistance point, it is at 120.17.
Ratios To Look Out For
It is important to note that Novartis AG ADR [NYSE:NVS] has a current ratio of 0.93. As well, the Quick Ratio is 0.72, while the Cash Ratio is 0.29. Considering the valuation of this stock, the price to sales ratio is 4.91, the price to book ratio is 5.79 and price to earnings (TTM) ratio is 15.21.
Transactions by insiders
Recent insider trading involved Kowalski Robert William, Officer, that happened on Aug 12 ’24 when 6566.0 shares were purchased.
